Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


EGFR inhibitor
BML-EI228-0010 10 mg 77.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: ALX-270-143

AG-494 is a member of the tyrphostin family of tyrosine kinase inhibitors and is a potent inhibitor of EGF receptor autophosphorylation (IC50=1.2 µM) and EGF-dependent cell growth (IC50=6 µM). It selectively inhibits HER1 (EGF receptor) vs. HER1-2 receptor autophosphorylation (HER1: IC50=1.1 µM; HER1-2: IC50=45 µM). HER1-2 is a chimeric receptor consisting of the external HER1 domain fused to an internal HER2 domain. Blocks CDK2 activation and causescells to arrest at late G1 and during S phase.

Product Specification

Purity:≥98% (TLC)
Appearance:Yellow solid.
Solubility:Soluble in DMSO (25mg/ml) or 100% ethanol (25mg/ml).
Long Term Storage:Ambient
Use/Stability:Product is subject to oxidation.
Handling:Store tightly sealed in the dark. Protect from light. Make solutions fresh daily.
Please mouse over

Product Literature References

Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase: N. Kleinberger-Doron, et al.; Exp. Cell Res. 241, 340 (1998), Abstract;
Tyrphostin AG 494 blocks Cdk2 activation: N. Osherov & A. Levitzki; FEBS Lett. 410, 187 (1997), Abstract;
Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins: N. Osherov, et al.; J. Biol. Chem. 268, 11134 (1993), Abstract;
Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases: A. Gazit, et al.; J. Med. Chem. 34, 1896 (1991), Abstract;

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2019 Enzo Life Sciences, Inc.,